Nick Doherty

Adheris LLC provides patient compliance and persistency program services. The company is headquartered in Burlington, MA.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ.

Steward Health Care System LLC engages in provision of profit physician led healthcare network. It offers community-based care, patient care model, business model, and Steward innovation. The company was founded by Ralph de la Torre and in headquartered in Dallas, TX.

Managed Markets Insight & Technology LLC provides formulary tools and solutions. Its web-based application supports all lines of business through extensive workflow and guidance functions as well as with multiple publishing mechanisms. The firm also provides a business logic layer to streamline synchronization across all major drug list providers. It specializes in mobile formulary search application and launch commercialization guidance. The company was founded in 1994 and is headquartered in Yardley, PA.

Mansa Capital Management LLC (Mansa Capital) is a private equity firm founded in 2003 by Ruben J. King-Shaw, Jr. The firm is headquartered in Boston, Massachusetts.

Kingswood Capital Management LLC (Kingswood Capital Mgmt) is a private equity firm founded in 2013 by Alexander Wolf. The firm is headquartered in Los Angeles, California.

OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD.